Effect on risk of anencephaly of gene-nutrient interactions between methylenetetrahydrofolate reductase C677T polymorphism and maternal folate, vitamin B12 and homocysteine profile

Public Health Nutrition

Volumn 15, Issue 8, 2012, Pages 1419-1428

  Lacasañ, Marina ^a,b   Blanco Muñoz, Julia ^c   Borja Aburto, Victor H ^d   Aguilar Garduño, Clemente ^e   Rodríaguez Barranco, Miguel ^a   Sierra Ramirez, José A ^f,g   Galaviz Hernandez, Carlos ^g   Gonzalez Alzaga, Beatriz ^a   Garcia Cavazos, Ricardo ^f,g  

^a ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^g National Institute Polytechnique   (Mexico)

Author keywords

Anencephaly; Folate; Homocysteine; Methylenetetrahydrofolate reductase polymorphism; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); VITAMIN B COMPLEX;

ADULT; ANENCEPHALUS; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; INFANT; METABOLISM; MEXICO; PREGNANCY; QUESTIONNAIRE; RISK FACTOR;

ADULT; ANENCEPHALY; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; INFANT; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MEXICO; POLYMORPHISM, GENETIC; PREGNANCY; QUESTIONNAIRES; RISK FACTORS; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 84864042779     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S136898001100334X     Document Type: Article

References (63)

1. International Clearinghouse for Birth Defects Monitoring System (2008) Annual Report 2008 with Data for 2006. Rome: The Centre of International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR), available at http://www.icbdsr.org/page.asp?p510065&l51
2. Blatter BM, Van der Star M & Roeleveld N (1994) Review of neural tube defects: risk factors in parental occupation and the environment. Environ Health Perspect 102, 140-145.
3. Copp AJ & Greene ND (2010) Genetics and development of neural tube defects. J Pathol 220, 217-230.
4. Botto LD & Yang Q (2000) 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151, 862-877. (Pubitemid 30461127)
5. Guéant JL, Guéant-Rodriguez RM, Anello G et al. (2003) Genetic determinants of folate and vitamin B12 metabolism: a common pathway in neural tube defect and Down syndrome? Clin Chem Lab Med 41, 1473-1477. (Pubitemid 37493563)
6. Gaber KR, Farag MK, Soliman SE et al. (2007) Maternal vitamin B12 and the risk of fetal neural defects in Egyptian patients. Clin Lab 53, 69-75. (Pubitemid 46350985)
7. Félix TM, Leistner S & Giugliani R (2004) Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil. Birth Defects Res A Clin Mol Teratol 70, 459-463. (Pubitemid 38998794)
8. Suarez L, Hendricks K, Felkner M et al. (2003) Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol 13, 81-88. (Pubitemid 36143706)
9. Martínez de Villarreal LE, Delgado-Enciso I, Valdéz-Leal R et al. (2001) Folate levels and N(5),N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study. Arch Med Res 32, 277-282.
10. Christensen B, Arbour L, Tran P et al. (1999) Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 84, 151-157. (Pubitemid 29201082)
11. Kirke PN, Molloy AM, Daly LE et al. (1993) Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86, 703-708.
12. Wild J, Schorah CJ, Sheldon TA et al. (1993) Investigation of factors influencing folate status in women who have had a neural tube defect-affected infant. Br J Obstet Gynaecol 100, 546-549. (Pubitemid 23186358)
13. Bagley PJ & Selhub J (1998) A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA 95, 13217-13220. (Pubitemid 28509551)
14. Boyles AL, Hammock P & Speer MC (2005) Candidate gene analysis in human neural tube defects. Am J Med Genet C Semin Med Genet 135C, 9-23. (Pubitemid 40593668)
15. Friso S & Choi SW (2005) Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 6, 37-46. (Pubitemid 40277880)
16. Holm PI, Hustad S, Ueland PM et al. (2007) Modulation of the homocysteine-betaine relationship by methylenetetrahydrofolate reductase 677C-T genotypes and B-vitamin status in a large-scale epidemiological study. J Clin Endocrinol Metab 92, 1535-1541. (Pubitemid 46556436)
17. Frosst P, Blom MJ, Lios R et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111-113.
18. Weisberg I, Tran P, Christensen B et al. (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64, 169-172. (Pubitemid 28453294)
19. Jakubowski H, Boers GH & Strauss KA (2008) Mutations in cystathionine b-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J 22, 4071-4076.
20. van der Put NM, Gabreels F, Stevens EM et al. (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neuraltube defects? Am J Hum Genet 62, 1044-1051. (Pubitemid 28199004)
21. Ulvik A, Ueland PM, Fredriksen A et al. (2007) Functional inference of the methylenetetrahydrofolate reductase 677C-T and 1298A-C polymorphisms from a large-scale epidemiological study. Hum Genet 121, 57-64. (Pubitemid 46421141)
22. Blanco-Muñoz J, Lacasaña M, Cavazos RG et al. (2007) Methylenetetrahydrofolate reductase gene polymorphisms and the risk of anencephaly in Mexico. Mol Hum Reprod 13, 419-424. (Pubitemid 47073581)
23. Mutchinick OM, Lopez MA, Luna L et al. (1999) High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metab 68, 461-467. (Pubitemid 30043552)
24. Gonzalez-Herrera L, Castillo-Zapata I, Garcia-Escalante G et al. (2007) A1298C polymorphism of the MTHFR gene and neural tube defects in the state of Yucatan, Mexico. Birth Defects Res A Clin Mol Teratol 79, 622-626. (Pubitemid 47291981)
25. Kirke PN, Mills JL, Molloy AM et al. (2004) Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ 328, 1535-1536. (Pubitemid 38850309)
26. Amorim MR, Lima MA, Castilla EE et al. (2007) Non-Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C-T: a meta-analysis. Am J Med Genet A 143, 1726-1732. (Pubitemid 47217270)
27. Shaw GM, Rozen R, Finnell RH et al. (1998) Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol 148, 30-37. (Pubitemid 28317542)
28. Scholl TO & Johnson WG (2000) Folic acid: influence on the outcome of pregnancy. Am J Clin 71, 5 Suppl., 1295S-1303S. (Pubitemid 30230532)
29. Harisha PN, Devi BI, Christopher R et al. (2010) Impact of 5,10-methylenetetrahydrofolate reductase gene polymorphism on neural tube defects. J Neurosurg Pediatr 6, 364-367.
30. Lacasaña M, Vázquez-Grameix H, Borja-Aburto VH et al. (2006) Maternal and paternal occupational exposure to agricultural work and the risk of anencephaly. Occup Environ Med 63, 649-656. (Pubitemid 44519001)
31. Garcia-Closas M & Lubin JH (1999) Power and sample size calculations in case-control studies of gene-environmental interactions: comments on different approaches. Am J Epidemiol 149, 689-693.
32. Willett WC (1998) Nutritional Epidemiology, 2nd ed. New York: Oxford University Press.
33. Hernández-Avila M, Romieu I, Parra S et al. (1998) Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex 40, 133-140. (Pubitemid 28257123)
34. Abbott Diagnostics Division (2001) IMx System Folate. Abbott Park, IL: Abbott Laboratories.
35. Abbott Diagnostics Division (1997) IMx System Vitamin B-12. Wiesbaden: Abbott Laboratories.
36. Abbott Diagnostics Division (2001) IMx System Homocysteine. Mexico DF: Abbott Laboratories.
37. Institute of Medicine (2002) Dietary Reference Intakes (DRI) for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press.
38. Cech I & Burau KD (2010) Serological differences in folate/ vitamin B12 in pregnancies affected by neural tube defects. South Med J 103, 419-424.
39. Davis BA, Bailey LB, Gregory JF et al. (1995) Folic acid absorption in women with a history of pregnancy with neural tube defect. Am J Clin Nutr 62, 782-784.
40. Ren A, Zhang L, Hao L et al. (2007) Comparison of blood folate levels among pregnant Chinese women in areas with high and low prevalence of neural tube defects. Public Health Nutr 10, 762-768. (Pubitemid 47038197)
41. Mitchell LE, Duffy DL, Duffy P et al. (1997) Genetic effects on variation in red-blood-cell folate in adults: implications for the familial aggregation of neural tube defects. Am JHum Genet 60, 433-438. (Pubitemid 27058415)
42. Molloy AM, Mills JL, Kirke PN et al. (1998) Whole blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: differences between the radioassay and microbiological assays. Clin Chem 44, 186-188.
43. Narayanan S, McConnell J, Little J et al. (2004) Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev 13, 1436-1443. (Pubitemid 39202309)
44. Perez AB, D'Almeida V, Vergani N et al. (2003) Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet A 119, 20-25. (Pubitemid 37063909)
45. Li D, Pickell L, Liu Y et al. (2006) Impact of methylenetetrahydrofolate reductase deficiency and low dietary folate on the development of neural tube defects in splotch mice. Birth Defects Res A Clin Mol Teratol 76, 55-59. (Pubitemid 43227678)
46. Bennett GD, Vanwaes J, Moser K et al. (2006) Failure of homocysteine to induce neural tube defects in a mouse model. Birth Defects Res B Dev Reprod Toxicol 77, 89-94.
47. Padmanabhan R, Shafiullah M, Benedict S et al. (2006) Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos. Eur J Nutr 45, 311-319. (Pubitemid 44386849)
48. Heidenreich DJ, Reedy MV & Brauer PR (2008) Homocysteine enhances cardiac neural crest cell attachment in vitro by increasing intracellular calcium levels. Dev Dyn 237, 2117-2128.
49. Blom HJ (2009) Folic acid, methylation and neural tube closure in humans. Birth Defects Res A Clin Mol Teratol 85, 295-302.
50. Wilson A, Platt R, Wu Q et al. (1999) A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 67, 317-323. (Pubitemid 29406795)
51. Lucock M, Daskalakis I, Hinkins M et al. (2001) An examination of polymorphic genes and folate metabolism in mothers affected by a spina bifida pregnancy. Mol Genet Metab 73, 322-332. (Pubitemid 32846371)
52. Relton CL, Wilding CS, Pearce MS et al. (2004) Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 41, 256-260. (Pubitemid 38496767)
53. O'Leary VB, Mills JL, Pangilinan F et al. (2005) Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol Genet Metab 85, 220-227. (Pubitemid 40840762)
54. Blom HJ, Shaw GM, den Heijer M et al. (2006) Neural tube defects and folate: case far from closed. Nat Rev Neurosci 7, 724-731. (Pubitemid 44267496)
55. Bruinse HW & van den Berg H (1995) Changes of some vitamin levels during and after normal pregnancy. Eur J Obstet Gynecol Reprod Biol 61, 31-37.
56. Cikot RJ, Steegers-Theunissen RP, Thomas CM et al. (2001) Longitudinal vitamin and homocysteine levels in normal pregnancy. Br J Nutr 85, 49-58. (Pubitemid 32156580)
57. McPartlin J, Halligan A, Scott JM et al. (1993) Accelerated folate breakdown in pregnancy. Lancet 341, 148-149. (Pubitemid 23029309)
58. O'Rourke KM, Redlinger TE & Waller DK (2000) Declining levels of erythrocyte folate during the postpartum period among Hispanic women living on the Texas-Mexico border. J Womens Health Gend Based Med 9, 397-403. (Pubitemid 30411751)
59. Relton CL, Wilding CS, Jonas PA et al. (2003) Genetic susceptibility to neural tube defect pregnancy varies with offspring phenotype. Clin Genet 64, 424-428. (Pubitemid 37406892)
60. Khoury MJ, Erickson JD & James LM (1982) Etiologic heterogeneity of neural tube defects: clues from epidemiology. Am J Epidemiol 115, 358-548.
61. Detrait ER, George TM, Etchevers HC et al. (2005) Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol 27, 515-524. (Pubitemid 40804442)
62. Elwood JM, Little J & Elwood JH (1992) Epidemiology and Control of Neural Tube Defects. Oxford: Oxford University Press.
63. Bell KN & Oakley GP Jr (2009) Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol 85, 102-107.